Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK/ERK1/2/Runx2 signalling axis-Reference-Cited by-同舟云学术

Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK/ERK1/2/Runx2 signalling axis

Published:2023-10 Issue: Volume:110 Page:110849
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Tyagi Komal,Roy Adhiraj,Mandal Supratim

Publisher

Elsevier BV

Subject

Cell Biology

Reference27 articles.

1. Epithelial ovarian cancer;Lheureux;Lancet [Internet],2019

2. High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints;Lisio;Int. J. Mol. Sci.,2019

3. Neoadjuvant chemotherapy in advanced epithelial ovarian cancer by histology: A SEER based survival analysis;Liu;Medicine (Baltimore) [Internet],2023

4. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials;du Bois;Cancer,2009

5. Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status;Gadducci;J. Ovarian. Res.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase C iota promotes glycolysis via PI3K/AKT/mTOR signalling in high grade serous ovarian cancer;Molecular Biology Reports;2024-09-14

2. Pharmacological inhibition of protein kinase D2/Aurora kinase A signalling axis suppresses G2/M cell cycle progression and proliferation of epithelial ovarian cancer cells;Pathology - Research and Practice;2024-08

3. Protein kinase D2-Aurora kinase A-ERK1/2 signalling axis drives neuroendocrine differentiation of epithelial ovarian cancer;Molecular and Cellular Biochemistry;2024-04-01

4. RUNX transcription factors: biological functions and implications in cancer;Clinical and Experimental Medicine;2024-03-02